Study identifier:AU-SEA-0002
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A piot study to examine the effectiveness, safety and tolerability of quetiapine in the treatment of anorexia nervosa (AN) in young people.
schizophrenia
Phase 3
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
-
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|